Header Logo

Connection

CHARLES WYKOFF to Aptamers, Nucleotide

Back to Details
This is a "connection" page, showing publications CHARLES WYKOFF has written about Aptamers, Nucleotide.
CHARLES WYKOFF
Connection Strength
0.204
Aptamers, Nucleotide
  1. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21; 402(10411):1449-1458.
    View in: PubMed
    Score: 0.204
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.